首页/数据集/miRNA promoters with hypermethylated DMRs in breast cancer cell lines.

miRNA promoters with hypermethylated DMRs in breast cancer cell lines.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_miRNA_promoters_with_hypermethylated_DMRs_in_breast_cancer_cell_lines_/178364 数据链接链接失效反馈

官方服务：

资源简介：

miRNA promoters with hypermethylated DMRs in breast cancer cell lines.

应用场景：

创建时间：

2015-12-02

乳腺癌表观遗传学

DNA6mA甲基化分析

Background: DNA N6-methyladenosine (6mA) as a novel epigenetic signaling modification in humans and has been implicated in progression and tumorigenesis of several cancers. However, the function and m

NIAID Data Ecosystem40

ZNF545 methylation and clinicopathologic features of breast tumors.

乳腺癌表观遗传学

肿瘤生物标志物

ZNF545 methylation and clinicopathologic features of breast tumors.

NIAID Data Ecosystem20

A methyl-deviator epigenotype of estrogen-receptor-positive breast carcinoma is associated with malignant biology. Homo sapiens

乳腺癌表观遗传学

癌症预后生物标志物

We broadly profiled DNA methylation in breast cancers (n=351) and benign parenchyma (n=47) for correspondence with disease phenotype using formalin-fixed paraffin-embedded (FFPE) diagnostic surgical p

NIAID Data Ecosystem20

Determinant of m6A regional preference by transcriptional dynamics

表观转录组学

RNA甲基化调控

N6-methyladenosine (m6A) is the most abundant chemical modification occurring on eukaryotic mRNAs, and has been reported to be involved in almost all stages of mRNA metabolism. The distribution of m6A

NIAID Data Ecosystem30

MOESM4 of Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer

乳腺癌表观遗传学

生物标志物预后

Additional file 4: Table S4. Association of GR methylation and clinical characteristics in MA.12 GR methylation study patients.

Figshare2019-11-02 更新20